GO
Loading...

Stocks to Watch: HRB, PAY, SVU & More

Wednesday, 5 Sep 2012 | 4:51 PM ET

Check out which companies are making headlines after the bell Wednesday:

H&R Block - The tax-preparation company posted a loss of 38 cents a share, edging past expectations for a loss of 39 cents a share. Meanwhile, the company posted a revenue of $96 million, missing estimates for $101 million. Shares were largely unchanged in after-hours trading. (Click here for after-hours quote.)

Verifone Systems - The electronic-payment technology provider posted earnings of 75 cents a share, excluding one-time items, on revenue of $493 million. Analysts expected the company to post a profit of 70 cents a share on sales of $498 million. In addition, the company provided a better-than-expected current-quarter, full-year 2012 and full-year 2013 earnings guidance. But it reported current-quarter and full-year 2013 revenue outlooks that disappointed, sending shares sharply lower in after-hours trading. (Click here for after-hours quote.)

Supervalu - The supermarket chain announced it will close approximately 60 underperforming stores this year. The move is expected to help the company make $35 million in cash within the next year and over $80 million in the next three years. Shares edged higher in after-hours trading. (Click here for after-hours quote.)

Warner Chilcott - The pharmaceutical company announced a 34 million secondary equity offering for holders through Citi. Shares of the company declined sharply after being briefly halted in after-hours trading. (Click here for after-hours quote.)

Korn/Ferry International - The executive-recruitment company posted earnings of 22 cents a share on revenue of $187 million, topping estimates for 18 cents a share on sales of $181 million. Meanwhile, the company handed in current-quarter revenue guidance that edged past expectations, while earnings were in line with projections. Shares gained in extended-hours trading. (Click here for after-hours quote.)

CIT Group - Oppenheimer initiated coverage of the financial services company with a "perform" rating. (Click here for after-hours quote.)

Dendreon - WallachBeth Capital initiated coverage of the biotech company with a "buy" rating and a price target of $11. (Click here for after-hours quote.)

Arena Pharmaceuticals - Credit Suisse initiated coverage of the pharmaceutical company with an "underperform" rating and a price target of $6. Meanwhile, the company initiated coverage of Orexigen with an "outperform" rating and a price target of $13. (Click here for after-hours quotes.)

—By CNBC’s JeeYeon Park (Follow JeeYeon on Twitter: @JeeYeonParkCNBC)

Questions? Comments? Email us at marketinsider@cnbc.com

  Price   Change %Change
ARNA
---

Featured

  • Patti Domm

    Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • A CNBC reporter since 1990, Bob Pisani covers Wall Street from the floor of the New York Stock Exchange.

  • Sharon Epperson is CNBC's senior commodities and personal finance correspondent.

  • JeeYeon Park is a writer for CNBC.com. Follow her on Twitter: @JeeYeonParkCNBC

  • Rick Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Senior Producer at CNBC's Breaking News Desk.

Executive Edge